Trade 294

BUY CRM

0.61852361 shares at $173.35 on 2026-04-23

Reasoning

CRM crashed 8.8% to $173.27 on sympathy selling from NOW's results, not company-specific deterioration. Fundamental backdrop remains strong: $25B buyback + dividend raise announced yesterday, P/E 20.8x vs 30.6x sector average, analyst consensus PT $261. This is a capitulation-level dip in a defensible name. However, applying Rule #27 ($500/day cap during April 29 binary window) and Rule #24 (thesis:buy requires corroboration). The buyback announcement provides corroboration, but sector contagion risk is real (ADBE -6.8%, IBM -8.4% on same SaaS panic). Current position ~$186 (6.3% portfolio). Reducing magnitude from $200 to $150 to respect Rule #27 deployment cap and preserve dry powder for April 29 post-earnings opportunities. Post-trade exposure will be ~9.2% of portfolio (within Rule #29 10% limit). This lowers avg cost meaningfully while maintaining optionality if sector contagion deepens.

Thesis

CRM position held near breakeven. Hyperscaler earnings show strong enterprise AI spending — GOOGL Cloud 63% growth, Azure 40%, AWS 28% — which supports enterprise SaaS demand. Agentforce platform should benefit from the AI enterprise buildout wave. However, CRM's own Q1 earnings June 3 is the key event. SaaS sector sentiment improving as enterprise AI spend proves out. Position at cost basis, acting as a call option on SaaS recovery. (long, medium confidence)

Outcome

7-day: +7.39% · 30-day: pending

Cited evidence

Theses